Terms: = Ovarian cancer AND PCSK7, Q16549, 9159, ENSG00000160613, PC8, SPC7, PC7, LPC AND Prognosis
2 results:
1. LDLR-mediated lipidome-transcriptome reprogramming in cisplatin insensitivity.
Chang WC; Wang HC; Cheng WC; Yang JC; Chung WM; Ho YP; Chen L; Hung YC; Ma WL
Endocr Relat Cancer; 2020 Feb; 27(2):81-95. PubMed ID: 31815680
[TBL] [Abstract] [Full Text] [Related]
2. Lysophospholipids are potential biomarkers of ovarian cancer.
Sutphen R; Xu Y; Wilbanks GD; Fiorica J; Grendys EC; LaPolla JP; Arango H; Hoffman MS; Martino M; Wakeley K; Griffin D; Blanco RW; Cantor AB; Xiao YJ; Krischer JP
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1185-91. PubMed ID: 15247129
[TBL] [Abstract] [Full Text] [Related]
